Checkpoint Therapeutics, Inc. - Common Stock (CKPT)

CUSIP: 162828206

Q3 2023 13F Holders as of 30 Sep 2023

Security identity
Security type / class
Equity / Common Stock
Shares outstanding
61,355,717
Holder snapshot
Total 13F shares
3,926,281
Share change
+1,259,841
Total reported value
$6,675,410
Put/Call ratio
127%
Reported price per share
$1.70
Number of holders
39
Value change
-$1,516,067
Number of buys
25
Number of sells
11

Security key

162828206

Report period

Q3 2023

Institutions

39

Top holders

10

CKPT full security history Ownership snapshot Full 13F holder table Newer quarter: Q4 2023 Previous quarter: Q2 2023

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of CKPT - Checkpoint Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
—
13D/G signal
—
Evidence rows
0
Latest as of
—
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

13F holder rows

Institutional holders as of Q3 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
39
Shares
3,926,281
Rows available
39
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q3 2023 vs Q2 2023 Across Filers

Q2 2023 holders
35
Q3 2023 holders
39
Holder diff
4
Investor Q2 2023 Shares Q3 2023 Shares Share Diff Share Chg % Q2 2023 value Q3 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .